Delusions, behavioural symptoms, quality of life and caregiver effects in AD Delusions, behavioural symptoms, quality of life and caregiver effects in.

Slides:



Advertisements
Similar presentations
Indianapolis Discovery Network for Dementia Comparative Effectiveness Research Trial of Alzheimers Disease Drug: COMET-AD.
Advertisements

Combining neuropsychology and genetics in the study of mood disorders Daniel Smith MRCPsych Division of Psychiatry, University of Edinburgh Specialist.
Speed of processing, the missing measure in early detection of MCI? Ruth O’Hara March 13 th 2001 Yogesh Shah.
Living well with dementia: more timely diagnosis and early intervention Louise Robinson Professor of Primary Care and Ageing RCGP National Clinical Champion.
Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
It is common practice for Neuropsychologists to administer the same tests on more than one occasion to document the progression of a patient’s cognitive.
Pediatric Chronic Pain and Differences in Parental Health-Related Quality of Life Gustavo R. Medrano¹, Susan T. Heinze¹, Keri R. Hainsworth 2,3, Steven.
New England Journal of Medicine October 18;367: Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease Molly Moncrieff.
Cognitive, neurological and adaptive behaviour functioning among children with perinatally-acquired HIV infection Anita Shet, Smitha Holla, Vijaya Raman,
PRACTICE PARAMETER: RISK OF DRIVING AND ALZHEIMER ’ S DISEASE (AN EVIDENCE-BASED REVIEW) Richard M. Dubinsky, MD; Anthony C. Stein, PhD; and Kelly Lyons,
Aim 2: Organizational Approach  PD patients demonstrated greater disorganization in copy trial approach than controls; t(2.09), p
Frontotemporal Dementia
Health service utilization by patients with common mental disorder identified by the Self Reporting Questionnaire in a primary care setting in Zomba, Malawi.
Brief Cognitive Assessment Tool (BCAT®) Training Program
NEURAL CIRCUITRY UNDERLYING IMPAIRED INSIGHT IN SCHIZOPHRENIA: AN FMRI STUDY Mark Benton Department of Psychiatry and Behavioral Neuroscience.
Mary Ganguli’s Slides March 13 th Meeting. Mild Cognitive Impairment A View from the Trenches.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
The New Brief Cognitive Assessment Tool (BCAT): The Role of Cognitive Assessment in Improving Health Outcomes Dr. William Mansbach October 25, 2011.
ACT on Alzheimer’s Disease Curriculum Module VII: Disease Diagnosis.
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
Dr. Omranifard MD 12 may 2015 Depression is one of the most prevalent psychiatric disorders in late life with devastating health consequences. It could.
Recreational Therapy: An Introduction Chapter 9: Geriatric Practice PowerPoint Slides.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Emotion Perception and Social Functioning in Serious Mental Illness: Differential Relationships Among Inpatients and Outpatients Melissa Tarasenko, Petra.
Introduction History of Childhood Abuse and Recovery of Neurocognition during Inpatient Psychiatric Rehabilitation: 18-Month Longitudinal Study Kee-Hong.
Musical Therapy for the Agitated Alzheimer's Patient By Stephanie Markarian.
Acknowledgments: Data for this study were collected as part of the CIHR Team: GO4KIDDS: Great Outcomes for Kids Impacted by Severe Developmental Disabilities.
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Designed by TheTemplateMart.com EVALUATING RESULTS OF A 6 MONTH INTERVENTION PROGRAM IN A DEMENTIA DAY CARE CENTER Efthymiou, A., Karpathiou, N., Dimakopoulou,
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
1 Patient Dependence, Function, and Changes in Cost of Care in Alzheimer’s Disease Carolyn W. Zhu JJP VA Medical Center, Mount Sinai School of Medicine.
Perceived Recovery as a Predictor of Physical Activity after Mild Stroke Jessica Koster, BA, MSOTS 1, & Timothy J. Wolf, OTD, MSCI, OTR/L 1,2 Washington.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
WHAT WE LEARNED In a clinically-referred, assisted living sample: 1.NAB Judgment (NAB-JDG) scores displayed good internal consistency reliability. 2.NAB-JDG.
Functional Impairment and Depressive Symptoms: Mitigating Effects of Trait Hope Jameson K. Hirsch, Ph.D. 1,2, S. Kaye, B.S. 1, & Jeffrey M. Lyness, M.D.
Down syndrome and Alzheimer’s disease: A retrospective medical records review Erin Klonoski LEND Fellow MPH Candidate April 30 th, 2010.
Dementia: Delivering the Diagnosis Daniel D. Christensen, M.D. Clinical Professor of Psychiatry Clinical Professor of Neurology Adjunct Professor of Pharmacology.
Ryoichi J. P. Noguchi, M.S., Michael M. Knepp, M.S., & Thomas H. Ollendick, Ph.D. INTRODUCTION METHOD  Studies of attention and memory have consistently.
Why Physicians Do Not Diagnose Alzheimer’s Disease Mark A. Sager, MD Professor of Medicine and Population Health Sciences Director, Wisconsin Alzheimer’s.
INTRODUCTION Early after injury, persons with mild traumatic brain injury (TBI) have been shown to experience physical, cognitive, and emotional difficulties.
CHAPTER 3 ASSESSMENT © 2013 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Are spatial tasks useful for the early diagnosis of Alzheimer’s disease.
CC-1 Benefit-Risk Assessment Murat Emre, MD Professor of Neurology Istanbul Faculty of Medicine Department of Neurology Behavioral Neurology and Movement.
MethodIntroductionResults Discussion Factors Affecting Psychosocial Functioning in Serious Mental Illness and Implications for Treatment Jason E. Vogler,
Assessment and Diagnosis of Dementia Dr Alison Haddow.
Ebrictus Register St Coordination Strategies of Care across Stroke recovery: Proposals for Nursing Intervention in Primary Care Teresa Forcadell-Arenas.
Background. Vascular Cognitive Impairment Vascular Cognitive Impairment (VCI) includes the cognitive and behavioural disorders associated with cerebrovascular.
Identifying and Tracking Changes in Cognition Related to NPH Sheldon Herring, Ph.D. Clinical Director Outpatient Brain Injury and Young Stroke Program.
Dyadic Patterns of Parental Perceptions of Health- Related Quality of Life Gustavo R. Medrano & W. Hobart Davies University of Wisconsin-Milwaukee Pediatric.
Additional Assessments. Clinicians are encouraged to communicate with the interprofessional team about other resources and next steps in terms of additional.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
Decision-Making Capacity - under the medical model Dr. Michael A. Valente.
Proposed Study of the Effect of Different Subtypes of Cognitive Impairment on the Capacity of Older Individuals to Manage Chronic Disorders.
Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.
Long-Term Outcomes after Acute Stroke Treatment Larry B. Goldstein, M.D. Professor of Medicine (Neurology) Center for Cerebrovascular Disease Center for.
Results Results Dillon C, MD, PhD; Vazquez G, MD, PhD ; Corrales A, MD; Allegri RF, MD, PhD; Taragano FE, MD, PhD. CEMIC University Hospital, SIREN, Department.
Health Related Quality of Life after serious occupational injuries and long term disability Presenter: Ibishi Nazmie MD,PhD University Clinical Center.
All Hands Meeting 2004 Ontologies for Data Mediation Christine Fennema-Notestine, Ph.D.
Insights into Verbal Planning Total score of core propositions
Differences in SPECT Perfusion in Children and Adolescents with ADHD
Exploring Executive Functioning in Patients with Frontal Lobe and Temporal Lobe Epilepsy Using a Novel Ecologically-Valid Virtual Reality Task: The Jansari.
The behavioral pathology in Alzheimer's Disease Scale; BEHAVE-AD
The BrainHealthRegistry
Brief Computerized Measures of Information Processing Speed are Sensitive to Multiple Sclerosis across the Lifespan M. Shaw1, C. Schwarz1, L.B. Krupp1,
The Impact of Smoking Cessation on Real-World Prospective Memory
Chapter 93 Dementias and Related Disorders
Interreg-IPA Cross-border Cooperation Programme Romania-Serbia
The effects of physical exercise on executive function in community dwelling older adults living with Alzheimer’s-type dementia: A systematic review.
Presentation transcript:

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Delusions, behavioural symptoms, quality of life and caregiver effects in Alzheimer’s Corinne E. Fischer MD FRCPC, Assistant Professor, University of Toronto, Director of the St. Michael’s Hospital Memory Disorders Clinic, St. Michael’s Hospital, Toronto, Canada

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Conflict of Interest Disclosure Corinne E Fischer, MD Has no real or apparent conflicts of interest to report.

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Background Delusions are a relatively common behavioural symptom of Alzheimer’s disease (AD) with a prevalence of about 31% (Bassiony et al 2000; Fischer et al, 2009). Prior studies have proposed a link between delusions and reduced frontal lobe integrity and function. Poor frontal lobe function has been linked to impaired performance of activities of daily living (ADLs) and instrumental ADLs (IADLs) (Royall et al 2002). This study examines whether delusional symptoms in AD are linked to more severe impairments in real world functioning. We predict the severity of real world function impairment will be mediated by deficits in frontal lobe abilities such as attention and executive function.

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Many prior studies have proposed a link between delusions and frontal lobe function Binetti et al (1995) compared CT scans of delusional and non-delusional AD patients and found delusional patients had significantly more white matter lesions SPECT studies have consistently shown decreased perfusion to the frontal lobes in delusional AD patients (Kotrla et al 1995, Mega et al 2000) PET study by Sultzer et al (2003) showed decrease glucose uptake in the right prefrontal cortex in delusional AD patients Background cont’d

Delusions, behavioural symptoms, quality of life and caregiver effects in AD

Neuropathological studies have demonstrated that delusional AD patients may have more senile plaques in the frontal lobes (Zubenko et al 1991) Neuropsychological studies have shown more impairment in frontal- executive tasks (Lopez et al 1997, Paulsen et al 2000) Data suggests that delusions in AD patients may be associated with a number of adverse outcomes, including worse behavioural symptoms premature admission to Long Term Care and increased caregiving (Gormely et al 1998, Harwood et al 1999) Recent data suggests that delusional AD patients may have worse functional performance (review, Fischer et al 2009) Background cont’d

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Objectives  To determine whether or not delusions in AD are associated with impairment in real world functioning.  To determine whether or not impairment in real world functioning in delusional AD persons is mediated by reduced frontal lobe function.  To determine whether impairment in real world functioning in delusional AD persons is associated with worse behavioural symptoms, reduced quality of life or increased caregiving.

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Methods Participants were recruited through outpatient clinics at St. Michael’s hospital and from several affiliated Long Term Care Homes. Participants and caregivers were administered neuropsychological tests (MMSE, NART, Trail Making Test, Boston Naming Test, Token Test, CVLT) and questionnaires to measure real world function (DADS), behaviour (BEHAVE-AD), quality of life (AD quality of life) and caregiver effects (caregiver burden scale). Means were compared between groups using a 1-tailed independent samples t-test.

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Results 15 delusional and 20 non-delusional AD participants have been tested thus far (matched for age and years of education). Both delusional and non-delusional AD participants performed similarly on a number of neuropsychological tests (MMSE, NART, Trail Making Test, Boston Naming Test, Token Test, CVLT) suggesting that their overall cognitive status is similar. Delusional AD participants performed worse than non-delusional AD participants during the planning stage of a verbal fluency task (first fifteen seconds) suggesting worse executive function.

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Delusional AD participants perform worse than non-delusional participants during the planning stage of word generation (which is the first 15 seconds of a verbal fluency task), suggesting more impairment in executive function

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Delusional AD participants have more behavioral changes as reported by their caregiver on the BEHAVE-AD. No differences were detected in quality life, however.

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Delusional AD participants have more impairment in instrumental activities of daily living than non-delusional AD participants

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Caregivers of delusional AD participants scored significantly higher on the Caregiver Burden Scale compared to caregivers of non-delusional AD participants

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Clinical Implications These findings support the existence of a strong link between delusions in AD, frontal lobe dysfunction and real-world functional impairment. Future fMRI studies should attempt to localize differences in frontal lobe activation between delusional and non-delusional AD persons. Delusional AD persons are also not able to perform the same instrumental activities of daily living than non delusional AD persons and have more global changes in behavior as reported by their caregivers. No differences in quality of life were detected, however. Furthermore, these changes in functional ability in delusional AD persons may also contribute to increased caregiving. Knowledge gained from this study may provide guidance around the management of delusional AD persons, leading to improved treatment outcomes for patients and their families.

Delusions, behavioural symptoms, quality of life and caregiver effects in AD Co-PI: Dr. Tom Schweizer Co-investigator: Dr. Zahinoor Ismail, Dr. Nathan Herrmann Neurology: Dr. Luis Fornazzari Research Assistants: Jemcy Joy, Lauren Forrest, Areeba Adnan Registered Nurse Clinicians: Lee Ringer, Marianne Saragosa Alzheimer Society of Canada Heather and Eric Donnelly Endowment, St. Michael’s Hospital Foundation, St. Michael’s Hospital Acknowledgements